Khanu Fondsverwaltung

Khanu Management (Khanu Fondsverwaltung GmbH) is a specialized venture capital and investment management firm based in Dortmund, Germany, focused on early-stage drug discovery. The firm manages the KHAN Technology Transfer Funds (KHAN-I and KHAN-II), which aim to bridge the gap between academic research and industrial drug development. Khanu operates in a unique ecosystem, maintaining a strategic partnership with the Max Planck Society and utilizing the Lead Discovery Center (LDC) as its primary drug discovery engine. The firm invests in and builds companies around innovative therapeutic assets, primarily in the fields of oncology, neurodegeneration, and metabolic diseases. By providing both funding and professional drug discovery expertise, Khanu facilitates the translation of high-quality basic research into commercially viable medicines.